Business Context and Reporting Period
Company: Nature's Sunshine Products, Inc.
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2006.
Business Overview: The Company manufactures and markets nutritional and personal care products (herbal products, vitamins, minerals) sold globally through a direct-selling network of independent Distributors and Managers. Operations are segmented into NSP United States, NSP International, and Synergy Worldwide.
Reporting Status: This filing is significantly delayed. The Company was delisted from the Nasdaq National Market in April 2006 due to failure to file periodic reports and currently trades on the Pink Sheets. The financial statements for 2004 and 2005 have been restated due to errors identified in an internal investigation regarding sales, commissions, and accounting practices.
Key Financial Metrics (Year Ended Dec 31, 2006)
| Metric | 2006 | 2005 | 2004 (Restated) |
|---|---|---|---|
| Net Sales Revenue | $362.2 million | $351.7 million | $325.3 million |
| Operating Income | $8.0 million | $11.6 million | $19.0 million |
| Net (Loss) Income | $(3.6) million | $3.5 million | $11.8 million |
| Diluted EPS | $(0.23) | $0.23 | $0.76 |
| Operating Margin | 2.2% | 3.3% | 5.8% |
| Effective Tax Rate | 141.3% | 69.3% | 43.1% |
| Cash & Equivalents | $39.1 million | $37.9 million | $32.7 million |
| Working Capital | $24.0 million | $27.9 million | $34.2 million |
| Long-term Obligations | $2.2 million | $2.3 million | $3.5 million |
Note: The 2006 net loss was driven by a 141% effective tax rate due to increased tax contingencies and valuation allowances, despite positive operating income.
Material Changes vs. Prior Period
- Profitability Decline: The Company transitioned from a net income of $3.5 million in 2005 to a net loss of $3.6 million in 2006. Operating income decreased by 31% ($11.6M to $8.0M).
- Expense Increases: Selling, General, and Administrative (SG&A) expenses rose by $11.2 million (8.7%) to $139.6 million. This increase was primarily due to $6.9 million in costs related to the internal investigation and $5.1 million in non-income tax contingencies.
- Revenue Growth: Net sales increased 3.0% to $362.2 million, driven by an 8.8% increase in NSP International sales, offset by flat US sales and a slight decline in Synergy Worldwide.
- Restatement Impact: The 2004 financial statements were restated, reducing previously reported net sales by $5.7 million and net income by $5.3 million due to revenue recognition errors, foreign consolidation issues, and tax adjustments.
Guidance, Risks, and Contingencies
Management Commentary & Outlook
Management expects to continue paying quarterly cash dividends ($0.05 per share). The Company intends to seek re-listing on a securities exchange once current in financial reporting, though no assurance is given regarding timing or approval. Liquidity is currently supported by cash flows from operations and existing cash balances ($39.1 million).
Material Risks and Contingencies
- SEC Proceedings: The SEC instituted an administrative proceeding to revoke the registration of the Company's common stock due to failure to file periodic reports. An administrative law judge issued an initial decision to revoke registration; the Company has petitioned for review, but the outcome is uncertain.
- Internal Control Weaknesses: The Company identified material weaknesses in internal controls over financial reporting, including the control environment, application of GAAP, income tax accounting, and IT systems. Deloitte & Touche LLP issued an adverse opinion on the effectiveness of internal controls.
- Legal Proceedings: A consolidated securities class action lawsuit is pending (trial scheduled for April 2010) alleging misrepresentations by management. The Company is also subject to ongoing investigations by the SEC and the Department of Justice (DOJ).
- Tax Contingencies: Significant accruals for income and non-income tax contingencies ($21.1 million total as of Dec 31, 2006) were recorded. The IRS is auditing returns for 2003-2005.
- Delisting: Continued trading on the Pink Sheets may adversely affect the trading market and price of the common stock.
Investor Verification Checklist
- Restatement Details: Verify the specific adjustments made to 2004 and 2005 financials in Note 2 to understand the full scope of prior accounting errors.
- SEC Status: Monitor the status of the SEC Section 12(j) proceeding regarding the potential revocation of stock registration.
- Internal Controls: Review the progress of remediation efforts for material weaknesses in internal controls, particularly regarding foreign operations and tax accounting.
- Tax Reserves: Assess the adequacy of the $21.1 million tax contingency reserve and the potential impact of the ongoing IRS audit.
- Litigation Exposure: Track the discovery phase of the securities class action lawsuit and any potential insurance coverage disputes.
- Liquidity: Confirm the Company's ability to fund operations and dividends without access to public capital markets while delisted.